A significant shift in U.S. drug policy just took shape. President Trump signed an executive order reclassifying marijuana from its current Schedule I status. This move signals a major turning point in how federal authorities view cannabis—and it could have ripple effects across the broader financial and asset markets. When regulatory frameworks shift this dramatically, investors typically reassess risk profiles and market sentiment. Keep an eye on how this shapes investor confidence and institutional participation in emerging asset classes.